Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2021.5109
Abstract: This cohort study investigates the immunogenicity and safety of a third SARS-CoV-2 vaccine dose in patients with multiple sclerosis who had a weak immune response to COVID-19 vaccination. read more here.
Keywords: immunogenicity safety; third sars; vaccine dose; safety third ... See more keywords
Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Medical Virology"
DOI: 10.1002/jmv.27629
Abstract: In March, people living with HIV infection (PLWH) were included in the risk category of fragile people for severe COVID‐19 receiving priority access to vaccination with BNT162b2 vaccine. The aim of the study was to… read more here.
Keywords: time; bnt162b2; mrna vaccine; immunogenicity safety ... See more keywords
Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2021.07.031
Abstract: Objectives The immunogenicity and safety of the Pfizer-BioNTech BNT162b2 mRNA vaccine in people living with HIV-1 (PLWH) are unknown. We thus aimed to assess the immunogenicity and safety of this vaccine in PLWH. Methods In… read more here.
Keywords: vaccine people; vaccine; immunogenicity safety; bnt162b2 mrna ... See more keywords
Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review
Sign Up to like & getrecommendations! Published in 2021 at "Value in Health"
DOI: 10.1016/j.jval.2021.09.003
Abstract: Objectives Emergence of severe acute respiratory syndrome coronavirus 2 infections and the resultant disease, COVID-19 led the world into 238 million cases and 4.8 million deaths over the first 22 months of the pandemic. While… read more here.
Keywords: covid; safety; immunogenicity safety; compared control ... See more keywords
Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): A systematic review.
Sign Up to like & getrecommendations! Published in 2020 at "Travel medicine and infectious disease"
DOI: 10.1016/j.tmaid.2020.101876
Abstract: BACKGROUND Tick-borne encephalitis (TBE) is increasing in Europe. We aimed to evaluate the immunogenicity and safety of TBE-vaccination. METHODS This systematic review was registered at PROSPERO (#CRD42020155737) and conducted in accordance with PRISMA guidelines. We… read more here.
Keywords: tbe; immunogenicity; tick borne; immunogenicity safety ... See more keywords
Immunogenicity and safety of human papillomavirus vaccine coadministered with other vaccines in individuals aged 9-25 years: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.10.092
Abstract: INTRODUCTION Adolescents and young adults are at a high risk of developing human papillomavirus (HPV) infections, which can be prevented with the use of vaccines. Moreover, a combined immunization strategy for administration of HPV vaccines… read more here.
Keywords: vaccine; administration; aged years; immunogenicity safety ... See more keywords
Immunogenicity and safety of seasonal influenza vaccines in children under 3 years of age.
Sign Up to like & getrecommendations! Published in 2023 at "Expert review of vaccines"
DOI: 10.1080/14760584.2023.2181797
Abstract: INTRODUCTION : Despite children aged 6-35 months developing more severe influenza infections, not all countries include influenza vaccines in their national immunization programs. AREAS COVERED : This literature review examines the efficacy, immunogenicity, and safety… read more here.
Keywords: immunogenicity safety; influenza vaccines; safety seasonal; influenza ... See more keywords
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
Sign Up to like & getrecommendations! Published in 2023 at "Journal of the Pediatric Infectious Diseases Society"
DOI: 10.1093/jpids/piad015
Abstract: Abstract In this ongoing study, substantially increased ancestral SARS-CoV-2 neutralizing responses were observed 1 month after a third 10-µg BNT162b2 dose given to 5 to 11-year olds versus neutralizing responses post-dose 2. After dose 3,… read more here.
Keywords: immunogenicity safety; year olds; bnt162b2; neutralizing responses ... See more keywords
Pharmacokinetics, immunogenicity, safety, and preliminary efficacy of subcutaneous turoctocog alfa pegol in previously treated patients with severe hemophilia A (alleviate 1)
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.14660
Abstract: The current standard of care for patients with hemophilia A is regular prophylaxis with factor VIII (FVIII) administered intravenously. Interest in subcutaneous (s.c.) administration, to potentially increase convenience, reduce the treatment burden and improve compliance,… read more here.
Keywords: subcutaneous turoctocog; preliminary efficacy; efficacy subcutaneous; immunogenicity safety ... See more keywords
THU0563 IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANKYLOSING SPONDYLITIS (PRELIMINARY RESULTS).
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.909
Abstract: Background: For the treatment of patients with ankylosing spondylitis (AS), biological drugs are widely used, which can effectively control the activity of the disease and radically change the prognosis. However, the use of these drugs… read more here.
Keywords: none; safety; vaccination; immunogenicity safety ... See more keywords
Randomized, double-blinded, controlled non-inferiority trials evaluating the immunogenicity and safety of fractional doses of Yellow Fever vaccines in Kenya and Uganda
Sign Up to like & getrecommendations! Published in 2019 at "Wellcome Open Research"
DOI: 10.12688/wellcomeopenres.15579.1
Abstract: Introduction: Yellow fever is endemic in specific regions of sub-Saharan Africa and the Americas, with recent epidemics occurring on both continents. The yellow fever vaccine is effective, affordable and safe, providing life-long immunity following a… read more here.
Keywords: yellow fever; vaccine; fractional doses; immunogenicity safety ... See more keywords